Effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Aliskiren (Primary) ; Losartan (Primary)
- Indications Hypertension; Metabolic syndrome
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.